Treatment of Refractory Chronic Pruritus of Unknown Origin With Tofacitinib in Patients With Rheumatoid Arthritis

JAMA DERMATOLOGY

AMER MEDICAL ASSOC

1. Doris Duke Charitable Foundation
2. Celgene Corporation
3. LEO Pharma
4. National Institute of Arthritis Musculoskeletal and Skin Diseases of the National Institutes of Health [NIH K08AR065577, R01AR070116]